Skip to search formSkip to main contentSkip to account menu

MBX-8025

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A selective peroxisome proliferator-activated receptor δ agonist PYPEP suppresses atherosclerosis in association with improvement of the serum lipoprotein profiles in human apolipoprotein B100 and…
2016
2016
A pilot study of MBX-8025 in the treatment of homozygous familial hypercholesterolemia (HoFH)
Review
2014
Review
2014
Role of selective peroxisome proliferator‐activated receptor modulators in managing cardiometabolic disease: tale of a roller‐coaster
Atherogenic dyslipidaemia is a hypertriglyceridaemic phenotype, associated with increased plasma concentrations of small, dense… 
2011
2011
World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease
INSULIN RESISTANCE: LIPID EFFECTS—Ronald Krauss (Berkley, CA) discussed lipid effects of peroxisome proliferator–activated… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)